ALT.AX : Summary for ANALYTICA FPO - Yahoo Finance

U.S. Markets closed

Analytica Ltd. (ALT.AX)


ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.01+0.00 (+16.67%)
As of 9:21 PM EST. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.01
Open0.01
Bid0.01 x
Ask0.01 x
Day's Range0.01 - 0.01
52 Week Range0.00 - 0.01
Volume2,400,000
Avg. Volume2,630,039
Market Cap15.66M
BetaN/A
PE Ratio (TTM)-2.33
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire5 months ago

    FDA approves PeriCoach® pelvic floor trainer for sale over-the-counter in the United States

    DENVER, July 13, 2016 /PRNewswire/ -- Analytica (ASX: ALT) today announced that the U.S. Food and Drug Administration (FDA) has approved the PeriCoach® at-home pelvic floor trainer device and smartphone app as an over-the-counter (OTC) treatment for treatment of mild, moderate and stress urinary incontinence (UI) and urge incontinence.  A strong pelvic floor is also associated with improved sexual function and satisfaction.

  • We're sorry this is all we were able to find about this topic.